<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Thrombolytic agents previously employed in the treatment of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> were associated with adverse side-effects and hemorrhagic complications </plain></SENT>
<SENT sid="1" pm="."><plain>The use of streptodekase (S), a Soviet trombolytic drug, which is a long-acting immobilized ensyme proved to be highly effective </plain></SENT>
<SENT sid="2" pm="."><plain>The efficacy of S in <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> was not investigated </plain></SENT>
<SENT sid="3" pm="."><plain>The authors report the use of S within the first 6-8 hours after an <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> in <z:mp ids='MP_0005048'>thrombosis</z:mp> of the main stem of the middle meningeal artery in one case and of the vertebral and main arteries with the development of the <z:e sem="disease" ids="C0023944" disease_type="Disease or Syndrome" abbrv="">locked-in syndrome</z:e> in the other </plain></SENT>
<SENT sid="4" pm="."><plain>In both cases the administration of S led to thrombolysis and restoration of the blood flow </plain></SENT>
<SENT sid="5" pm="."><plain>The authors discuss the results of the use of S and indicate the necessity of the earliest possible administration of the drug with regard to a high sensitivity of the brain to ischemic lesions </plain></SENT>
</text></document>